Baird Medical Investment Holdings Limited
BDMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 17.7% | -10.4% | 26.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 88.2% | 86.6% | 79.9% | 83.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 43.7% | 40.9% | 46.4% | 51.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 33.6% | 33.5% | 35.8% | 42.1% |
| EPS Diluted | 0.49 | 0.41 | 0.022 | -0.024 |
| % Growth | 19.5% | 1,789.4% | 189.7% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |